Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 6.878
Filter
1.
PLoS One ; 19(5): e0302783, 2024.
Article in English | MEDLINE | ID: mdl-38753660

ABSTRACT

BACKGROUND: Periprosthetic joint infection (PJI) is one of the most serious and debilitating complications that can occur after total joint arthroplasty. Therefore, early diagnosis and appropriate treatment are important for a good prognosis. Recently, molecular diagnostic methods have been widely used to detect the causative microorganisms of PJI sensitively and rapidly. The Multiplex Loop-Mediated Isothermal Amplification (LAMP) method eliminates the complex temperature cycling and delays caused by temperature transitions seen in polymerase chain reaction (PCR) methods, making it faster and easier to perform compared to PCR-based assays. Therefore, this study developed a multiplex LAMP assay for diagnosing bacterial PJI using LAMP technology and evaluated its analytical and clinical performance. METHODS: We developed a multiplex LAMP assay for the detection of five bacteria: Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus agalactiae, Pseudomonas aeruginosa, and Escherichia coli, frequently observed to be the causative agents of PJI. The method of analytical sensitivity and cross-reactivity were determined by spiking standard strains into the joint synovial fluid. The analytical sensitivity of the multiplex LAMP assay was compared with that of a quantitative real-time PCR (qPCR) assay. Clinical performance was evaluated using 20 joint synovial fluid samples collected from patients suspected of having bacterial PJI. RESULTS: The analytical sensitivity of the gram-positive bacterial multiplex LAMP assay and qPCR were 105/104 CFU/mL, 103/103 CFU/mL, and 105/104 CFU/mL against S. agalactiae, S. epidermidis, and S. aureus, respectively. For P. aeruginosa and E. coli, the analytical sensitivity of the multiplex LAMP and qPCR assays were 105/104 and 106/104 CFU/mL, respectively. The multiplex LAMP assay detects target bacteria without cross-reacting with other bacteria, and exhibited 100% sensitivity and specificity in clinical performance evaluation. CONCLUSIONS: This multiplex LAMP assay can rapidly detect five high-prevalence bacterial species causing bacterial PJI, with excellent sensitivity and specificity, in less than 1 h, and it may be useful for the early diagnosis of PJI.


Subject(s)
Molecular Diagnostic Techniques , Nucleic Acid Amplification Techniques , Prosthesis-Related Infections , Humans , Nucleic Acid Amplification Techniques/methods , Prosthesis-Related Infections/diagnosis , Prosthesis-Related Infections/microbiology , Molecular Diagnostic Techniques/methods , Sensitivity and Specificity , Staphylococcus epidermidis/isolation & purification , Staphylococcus epidermidis/genetics , Synovial Fluid/microbiology , Bacterial Infections/diagnosis , Bacterial Infections/microbiology , Staphylococcus aureus/isolation & purification , Staphylococcus aureus/genetics
2.
PLoS One ; 19(5): e0302785, 2024.
Article in English | MEDLINE | ID: mdl-38768150

ABSTRACT

INTRODUCTION: The rates of gonorrhea and chlamydia have been increasing in the years preceding the COVID19 pandemic. Because most gonorrhea and chlamydia infections are located in the oropharynx and rectum for men who have sex with men (MSM), and because at-home self-collected swabs for these infections are not licensed by Health Canada or the United States Food and Drug Administration, decreased accessed to in-person care during and since the COVID19 pandemic potentially means missed case findings. OBJECTIVES: To evaluate the performance of at-home self-collected pharyngeal and rectal swabs for gonorrhea and chlamydia nucleic acid amplification testing. METHODOLOGY: All persons who contacted our Sexual Health Clinic and who had a clinical indication to complete oral and/or rectal swabs for gonorrhea and chlamydia were invited to complete at-home swabs in advance of their scheduled appointments. We mailed swabs and instructions to those who consented. Participants brought these swabs to their scheduled in clinic appointments, where we repeated the same swabs. All matching swabs were sent to the laboratory for analysis to determine concordance. RESULTS: From September 8, 2022 to July 18, 2023, we enrolled 296 eligible participants who provided 1184 swabs. For analysis, cancelled specimens and specimens with invalid results were excluded, leaving 1032 swabs for comparison. We identified 66 STI diagnoses in 47 unique participants. Overall accuracy was high (exceeding 99%), except for rectal chlamydia, which was 96.0%. While the performance of self-swabs for chlamydia was lower compared to gonorrhea, at-home swabs identified six chlamydia infections that were missed by in-clinic collected swabs (two pharyngeal, four rectal). Removing these six cases as "false positives" increased overall accuracy for chlamydia detection to 99.7% (pharyngeal) and 97.8% (rectal). CONCLUSION: Self-collected at-home swabs had good performance acceptable for gonorrhea and chlamydia nucleic acid amplification testing.


Subject(s)
Chlamydia Infections , Chlamydia trachomatis , Gonorrhea , Neisseria gonorrhoeae , Pharynx , Rectum , Specimen Handling , Humans , Chlamydia trachomatis/isolation & purification , Chlamydia trachomatis/genetics , Chlamydia Infections/diagnosis , Chlamydia Infections/microbiology , Gonorrhea/diagnosis , Gonorrhea/microbiology , Male , Neisseria gonorrhoeae/isolation & purification , Neisseria gonorrhoeae/genetics , Rectum/microbiology , Pharynx/microbiology , Specimen Handling/methods , Adult , Female , Nucleic Acid Amplification Techniques/methods , Homosexuality, Male , Middle Aged , Self Care , Young Adult
3.
Anal Chim Acta ; 1307: 342560, 2024 Jun 08.
Article in English | MEDLINE | ID: mdl-38719398

ABSTRACT

BACKGROUND: Point-of-care (POC) nucleic acid amplification tests (NAAT) can significantly expand testing coverage, which is critical for infectious disease diagnostics and monitoring. The development of various isothermal amplification techniques greatly simplifies NAATs, but the cumbersome nucleic acid extraction step remains a bottleneck for the POC. Alternatively, extraction-free amplification, where crude samples are directly added into the assay, substantially simplifies the workflow. However, sample dilution is often needed in extraction-free amplification to reduce assay inhibition from sample matrices. Since NAATs are typically run at small volumes around 20 µL, the input sample quantity is therefore limited, resulting in an inevitable sensitivity loss. RESULTS: Here we explore the potential to perform isothermal amplification in larger reaction volumes to accommodate larger sample quantities, thereby improving sensitivity in extraction-free amplification. We demonstrated the approach by developing large-volume reverse transcription loop-mediated isothermal amplification (RT-LAMP) for HIV RNA detection from fingerstick plasma. We found that LAMP at reaction volumes up to 1 mL maintained the same performance. We then identified plasma dilution conditions needed to maintain the limit of detection in RT-LAMP. Subsequently, using inactivated HIV virus, we showed the successful detection of 24 HIV RNA copies in a 500 µL RT-LAMP reaction in the presence of 20 µL plasma (fingerstick volumes), translating to a viral load of 1200 copies per mL. To reduce the increased reagent cost with expanded reaction volumes, we further identified lower-cost reagents with maintained assay performance. Moreover, we showed that large-volume LAMP, compared to 20 µL reactions, could tolerate higher concentrations of various inhibitors in the sample, such as albumin and GuSCN. SIGNIFICANCE AND NOVELTY: NAATs are conventionally conducted at small reaction volumes. Here we demonstrated that LAMP can be run at large reaction volumes (over 100 µL) with maintained assay performance, allowing sample inhibition to be mitigated while accommodating larger sample quantities. The same strategy of expanding reaction volumes could be applied to other isothermal amplification methods and various POC applications, to streamline test workflows and/or improve assay sensitivity.


Subject(s)
Nucleic Acid Amplification Techniques , RNA, Viral , Nucleic Acid Amplification Techniques/methods , Humans , RNA, Viral/blood , HIV Infections/blood , HIV Infections/diagnosis , HIV Infections/virology , HIV-1/genetics , HIV-1/isolation & purification , Limit of Detection , Molecular Diagnostic Techniques
4.
J Assoc Physicians India ; 72(3): 14-17, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38736110

ABSTRACT

BACKGROUND: Exudative pleural effusions are commonly encountered in clinical practice, but in about one-fourth of cases, etiology remains elusive after initial evaluation. Medical thoracoscopy with semirigid thoracoscope is a minimally invasive procedure with high diagnostic yield for diagnosing pleural diseases, especially these undiagnosed exudative pleural effusions. In tubercular endemic areas, often, these effusions turn out to be tubercular, but the diagnosis of tubercular pleural effusion is quite challenging due to the paucibacillary nature of the disease. Although culture is the gold standard, it is time-consuming. Cartridge-based nucleic acid amplification test (CBNAAT) is a novel rapid diagnostic test for tuberculosis (TB) and has been recommended as the initial diagnostic test in patients suspected of having extrapulmonary TB (EPTB). MATERIALS AND METHODS: We conducted a prospective observational study of 50 patients with undiagnosed pleural effusion admitted to our tertiary care hospital. The primary aim of the study is to evaluate the diagnostic performance of CBNAAT on thoracoscopic guided pleural biopsy and compare it with conventional diagnostic techniques like histopathology and conventional culture. RESULTS: Of 50 undiagnosed pleural effusions, TB (50%) was the most common etiology. The overall diagnostic yield of semirigid thoracoscopy in this study was 74%. Our study showed that CBNAAT of pleural biopsies had a sensitivity of 36% only but a specificity of 100%. The sensitivity of CBNAAT was not far superior to the conventional culture. CONCLUSION: Tuberculosis (TB) is a common cause of undiagnosed pleural effusion in our set-up. CBNAAT testing of pleural biopsy, though, is a poor rule-out test for pleural TB, but it may aid in the early diagnosis of such patients.


Subject(s)
Nucleic Acid Amplification Techniques , Pleural Effusion , Thoracoscopy , Tuberculosis, Pleural , Humans , Pleural Effusion/diagnosis , Thoracoscopy/methods , Prospective Studies , India , Female , Nucleic Acid Amplification Techniques/methods , Male , Middle Aged , Tuberculosis, Pleural/diagnosis , Adult , Sensitivity and Specificity , Biopsy/methods , Pleura/pathology , Aged
5.
Sci Rep ; 14(1): 10612, 2024 05 09.
Article in English | MEDLINE | ID: mdl-38719936

ABSTRACT

Molecular diagnostics involving nucleic acids (DNA and RNA) are regarded as extremely functional tools. During the 2020 global health crisis, efforts intensified to optimize the production and delivery of molecular diagnostic kits for detecting SARS-CoV-2. During this period, RT-LAMP emerged as a significant focus. However, the thermolability of the reagents used in this technique necessitates special low-temperature infrastructure for transport, storage, and conservation. These requirements limit distribution capacity and necessitate cost-increasing adaptations. Consequently, this report details the development of a lyophilization protocol for reagents in a colorimetric RT-LAMP diagnostic kit to detect SARS-CoV-2, facilitating room-temperature transport and storage. We conducted tests to identify the ideal excipients that maintain the molecular integrity of the reagents and ensure their stability during room-temperature storage and transport. The optimal condition identified involved adding 5% PEG 8000 and 75 mM trehalose to the RT-LAMP reaction, which enabled stability at room temperature for up to 28 days and yielded an analytical and diagnostic sensitivity and specificity of 83.33% and 90%, respectively, for detecting SARS-CoV-2. This study presents the results of a lyophilized colorimetric RT-LAMP COVID-19 detection assay with diagnostic sensitivity and specificity comparable to RT-qPCR, particularly in samples with high viral load.


Subject(s)
COVID-19 , Colorimetry , Freeze Drying , Molecular Diagnostic Techniques , Nucleic Acid Amplification Techniques , RNA, Viral , SARS-CoV-2 , Humans , COVID-19/diagnosis , COVID-19/virology , SARS-CoV-2/isolation & purification , SARS-CoV-2/genetics , Colorimetry/methods , Nucleic Acid Amplification Techniques/methods , Molecular Diagnostic Techniques/methods , RNA, Viral/analysis , RNA, Viral/genetics , Sensitivity and Specificity , Reagent Kits, Diagnostic/standards , COVID-19 Nucleic Acid Testing/methods
6.
Sci Rep ; 14(1): 10064, 2024 05 02.
Article in English | MEDLINE | ID: mdl-38698011

ABSTRACT

This study aims to establish a rapid diagnostic method for Streptococcus agalactiae (GBS) based on recombinase polymerase amplification (RPA) and lateral flow strips (LFS). The best primer pairs designed by SIP gene were screened according to the basic RPA reaction, then the probe was designed. The reaction condition was optimized based on the color development of the LFS detection line. To ascertain the reaction specificity, 10 common clinical pathogens and 10 clinical specimens of GBS were tested. Furthermore, the reaction sensitivity was assessed by utilizing a tenfold gradient dilution of GBS genomic DNA as templates. RPA-LFS method was compared to the qPCR assay and biochemical culture method for the Kappa consistency test. The RPA-LFS technique was able to complete the amplification process within 30 min and the results were observed on lateral flow strips. The method is highly sensitive, with a minimum detection limit of 1.31 ng for GBS. The RPA-LFS method showed consistent accuracy of results compared to qPCR and the culture-biochemical method. The establishment of this method is conducive to the development of on-site immediate detection, which can provide information for the timely development of a reasonable antimicrobial treatment plan, and has a greater potential for clinical application.


Subject(s)
Nucleic Acid Amplification Techniques , Recombinases , Streptococcal Infections , Streptococcus agalactiae , Streptococcus agalactiae/genetics , Streptococcus agalactiae/isolation & purification , Humans , Recombinases/metabolism , Nucleic Acid Amplification Techniques/methods , Streptococcal Infections/diagnosis , Streptococcal Infections/microbiology , Sensitivity and Specificity , DNA, Bacterial/genetics , Limit of Detection
7.
Sci Rep ; 14(1): 10169, 2024 05 03.
Article in English | MEDLINE | ID: mdl-38702375

ABSTRACT

Bovine viral diarrhea virus (BVDV) is considered to be the most common agent of severe diarrhea in cattle worldwide, causing fever, diarrhea, ulcers, and abortion. Bovine herpesvirus 1 (BoHV-1) is also a major bovine respiratory disease agent that spreads worldwide and causes extensive damage to the livestock industry. Recombinase polymerase amplification (RPA) is a novel nucleic acid amplification method with the advantages of high efficiency, rapidity and sensitivity, which has been widely used in the diagnosis of infectious diseases. A dual RPA assay was developed for the simultaneous detection of BVDV and BoHV-1. The assay was completed at a constant temperature of 37 °C for 30 min. It was highly sensitive and had no cross-reactivity with other common bovine viruses. The detection rate of BVDV RPA in clinical samples (36.67%) was higher than that of PCR (33.33%), the detection rate of BoHV-1 RPA and PCR were equal. Therefore, the established dual RPA assay for BVDV and BoHV-1 could be a potential candidate for use as an immediate diagnostic.


Subject(s)
Diarrhea Viruses, Bovine Viral , Herpesvirus 1, Bovine , Nucleic Acid Amplification Techniques , Recombinases , Animals , Cattle , Herpesvirus 1, Bovine/genetics , Herpesvirus 1, Bovine/isolation & purification , Nucleic Acid Amplification Techniques/methods , Recombinases/metabolism , Diarrhea Viruses, Bovine Viral/genetics , Diarrhea Viruses, Bovine Viral/isolation & purification , Sensitivity and Specificity , Bovine Virus Diarrhea-Mucosal Disease/virology , Bovine Virus Diarrhea-Mucosal Disease/diagnosis , Herpesviridae Infections/veterinary , Herpesviridae Infections/virology , Herpesviridae Infections/diagnosis , DNA, Viral/genetics
8.
Anal Methods ; 16(19): 3020-3029, 2024 May 16.
Article in English | MEDLINE | ID: mdl-38690766

ABSTRACT

A concise and rapid detection method for Mycoplasma pneumoniae is urgently required due to its severe impact on human health. To meet such a need, this study proposed and constructed an innovative point-of-care testing (POCT) platform that consists of a hydrogen ion-selective loop-mediated isothermal amplification (H+-LAMP) sensor and an electrochemical detection device. The H+-LAMP sensor successfully integrated the working and reference electrodes and converted the H+ generated during the LAMP process into an electrochemical signal. High sensitivity and stability for pathogen detection were also achieved by treating the working electrode with an electrodeposited polyaniline solid contact layer and by using an ion-selective membrane. As a result, the sensor shows a sensitivity of 68.26 mV per pH, a response time of less than 2 s, and a potential drift of less than 5 mV within one hour, which well meets the urgent need. The results also demonstrated that the detection limit for Mycoplasma pneumoniae was lowered to 1 copy per µL, the nucleic acid extraction and detection process could be completed in 30 minutes, and the impact of interfering ions on the sensor was negligible. Validation with 20 clinical samples yielded satisfactory results. More importantly, the storage lifespan of such an electrochemical sensor is over seven days, which is a great advantage for on-site pathogen detection. Therefore, the hydrogen ion-selective sensor constructed in this investigation is particularly suitable as a core component for instant pathogen detection platforms.


Subject(s)
Electrochemical Techniques , Limit of Detection , Mycoplasma pneumoniae , Nucleic Acid Amplification Techniques , Mycoplasma pneumoniae/isolation & purification , Mycoplasma pneumoniae/genetics , Electrochemical Techniques/methods , Electrochemical Techniques/instrumentation , Nucleic Acid Amplification Techniques/methods , Humans , Hydrogen/chemistry , Pneumonia, Mycoplasma/diagnosis , Pneumonia, Mycoplasma/microbiology , Biosensing Techniques/methods , Molecular Diagnostic Techniques/methods , Molecular Diagnostic Techniques/instrumentation , Electrodes
9.
Methods Mol Biol ; 2804: 195-206, 2024.
Article in English | MEDLINE | ID: mdl-38753149

ABSTRACT

Clinical diagnostics of infectious diseases via nucleic acid amplification tests (NAATs) depend on a separate step of isolation of nucleic acids from cells/viruses embedded in complex biological matrices. The most recent example has been reverse transcription polymerase chain reaction (RT-PCR) for amplification and detection of SARS-CoV-2 RNA for COVID-19 diagnostics. Kits for RNA extraction and purification are commercially available; however, their integration with amplification systems is generally lacking, resulting in two separate steps, i.e., sample preparation and amplification. This makes NAATs more time-consuming, requiring skilled personnel, and can increase the likelihood of contamination. Here, we describe a setup and methodology to perform the quick extraction and detection of nucleic acids in an integrated manner. In particular, we focus on the use of an immiscible filtration device for capture, isolation, concentration, amplification, and colorimetric detection of SARS-CoV-2 RNA.


Subject(s)
COVID-19 , Filtration , Nucleic Acid Amplification Techniques , RNA, Viral , SARS-CoV-2 , RNA, Viral/isolation & purification , RNA, Viral/analysis , RNA, Viral/genetics , Humans , SARS-CoV-2/isolation & purification , SARS-CoV-2/genetics , Nucleic Acid Amplification Techniques/methods , Nucleic Acid Amplification Techniques/instrumentation , COVID-19/diagnosis , COVID-19/virology , Filtration/instrumentation , Filtration/methods , COVID-19 Nucleic Acid Testing/methods , COVID-19 Nucleic Acid Testing/instrumentation , Colorimetry/methods , Colorimetry/instrumentation
10.
Anal Chim Acta ; 1309: 342693, 2024 Jun 22.
Article in English | MEDLINE | ID: mdl-38772660

ABSTRACT

BACKGROUND: CRISPR-Cas12a based one-step assays are widely used for nucleic acid detection, particularly for pathogen detection. However, the detection capability of the one-step assay is reduced because the Cas12a protein competes with the isothermal amplification enzymes for the target DNA and cleaves it. Therefore, the key to improving the sensitivity of the one-step assay is to address the imbalance between isothermal amplification and CRISPR detection. In previous study, we developed a Cas12a one-step assay using single-stranded DNA (ssDNA)-modified crRNA (mD-crRNA) and applied this method for the detection of pathogenic DNA. RESULTS: Here, we utilized mD-crRNA to establish a sensitive one-step assay that enables the visual detection of SARS-CoV-2 under ultraviolet light, achieving a detection limit of 5 aM without cross-reactivity. The sensitivity of mD-crRNA in the one-step assay was 100-fold higher than that of wild-type crRNA. Mechanistic studies revealed that the addition of ssDNA at the 3' end of mD-crRNA attenuates the binding affinity between the Cas12a-mD-crRNA complex and the target DNA. Consequently, this reduction in binding affinity decreases the cis-cleavage activity of Cas12a, mitigating its cleavage of the target DNA in the one-step assay. As a result, there is an augmentation in the amplification and accumulation of target DNA, thereby enhancing detection sensitivity. In the clinical testing of 40 SARS-CoV-2 RNA samples, the concordance between the results of the one-step assay and known qPCR results was 97.5 %. SIGNIFICANCE: The one-step assay using mD-crRNA proves to be highly sensitive and specificity and visually effective for the detection of SARS-CoV-2. Our study delves into the application of the mD-crRNA-mediated one-step assay in nucleic acid detection and its associated reaction mechanism. This holds great significance in addressing the inherent incompatibility issues between isothermal amplification and CRISPR detection.


Subject(s)
COVID-19 , DNA, Single-Stranded , Nucleic Acid Amplification Techniques , RNA, Viral , SARS-CoV-2 , SARS-CoV-2/genetics , SARS-CoV-2/isolation & purification , DNA, Single-Stranded/chemistry , DNA, Single-Stranded/genetics , Nucleic Acid Amplification Techniques/methods , Humans , RNA, Viral/analysis , RNA, Viral/genetics , COVID-19/diagnosis , COVID-19/virology , Limit of Detection , CRISPR-Cas Systems/genetics , Endodeoxyribonucleases/chemistry , Endodeoxyribonucleases/metabolism , Endodeoxyribonucleases/genetics , CRISPR-Associated Proteins/metabolism , CRISPR-Associated Proteins/genetics , Bacterial Proteins
11.
Sci Rep ; 14(1): 11542, 2024 May 21.
Article in English | MEDLINE | ID: mdl-38773154

ABSTRACT

Evidence for seed transmission of phytoplasmas has grown in several pathosystems including coconut (Cocos nucifera). Bogia coconut syndrome (BCS) is a disease associated with the lethal yellowing syndrome associated with the presence of 'Candidatus Phytoplasma noviguineense' that affects coconut, betel nut (Areca catechu) and bananas (Musa spp.) in Papua New Guinea. Coconut and betel nut drupes were sampled from BCS-infected areas in Papua New Guinea, dissected, the extracted nucleic acid was used in polymerase chain reaction (PCR), and loop mediated isothermal amplification (LAMP) used to check for presence of phytoplasma DNA. In a second study, drupes of both plant species were collected from multiple field sites and grown in insect-proof cages. Leaf samples taken at 6 months were also tested with PCR and LAMP. The studies of dissected coconut drupes detected phytoplasma DNA in several tissues including the embryo. Drupes from betel nut tested negative. Among the seedlings, evidence of possible seed transmission was found in both plant species. The results demonstrate the presence of 'Ca. P. noviguineense' in coconut drupes and seedlings, and in seedlings of betel nut; factors that need to be considered in ongoing management and containment efforts.


Subject(s)
Areca , Cocos , Phytoplasma , Plant Diseases , Seedlings , Seeds , Cocos/microbiology , Phytoplasma/genetics , Phytoplasma/isolation & purification , Seeds/microbiology , Plant Diseases/microbiology , Seedlings/microbiology , Nucleic Acid Amplification Techniques/methods , DNA, Bacterial/genetics , Papua New Guinea , Polymerase Chain Reaction , Molecular Diagnostic Techniques
12.
Int J Mycobacteriol ; 13(1): 96-99, 2024 Jan 01.
Article in English | MEDLINE | ID: mdl-38771286

ABSTRACT

BACKGROUND: The most common organ affected due to tuberculosis (TB) is the lungs. Extrapulmonary TB is less common. Musculoskeletal organs are affected in around 8% of all tubercular patients, of which the spine is affected in almost half of the patients. The criteria for diagnosing spinal TB are quite difficult and we use an array of investigations for the same. METHODS: A retrospective study was carried out in the Neurosurgery and Microbiology Department at IMS and SUM Hospital between January 2021 and November 2023, and data were collected and tabulated in an Excel sheet. One hundred patients with spinal TB were evaluated, and their age, sex, samples sent, diagnostic investigation, duration of diagnosis from hospital admission, histopathology results, and surgical intervention (done or not) were recorded. RESULTS: The best investigation done to diagnose spinal TB was imaging and surgical/computed tomography (CT)-guided biopsy. The earliest result to diagnose spinal TB was histopathology. The yield of positivity in pus culture, smear microscopy, and true nucleic acid amplification test (NAAT) was found to be low even though sensitivity was on the higher side. CONCLUSION: Even though we have an array of investigations for diagnosing spinal TB, the best and the earliest diagnosing test was imaging plus CT-guided biopsy. The confirmation is made in the biopsy. Finding acid-fast bacteria (AFB) and NAAT tests are additional beneficial tests to supplement the diagnosis. Hence, we can conclude that sending for tests like AFB in pus, NAAT, and GeneXpert is a wastage of biological samples and delays in diagnosis.


Subject(s)
Mycobacterium tuberculosis , Tuberculosis, Spinal , Humans , Tuberculosis, Spinal/diagnosis , Tuberculosis, Spinal/microbiology , Retrospective Studies , Male , Female , Adult , Middle Aged , Mycobacterium tuberculosis/isolation & purification , Mycobacterium tuberculosis/genetics , Young Adult , Aged , Tomography, X-Ray Computed , Adolescent , Biopsy , Nucleic Acid Amplification Techniques/methods , Sensitivity and Specificity
13.
Mikrochim Acta ; 191(6): 334, 2024 05 17.
Article in English | MEDLINE | ID: mdl-38758362

ABSTRACT

Single nucleotide polymorphism (SNP) biosensors are emerging rapidly for their promising applications in human disease prevention diagnosis, treatment, and prognosis. However, it remains a bottleneck in equipping simple and stable biosensors with the traits of high sensitivity, non-enzyme, and low cost. Double base mismatches mediated chain displacement reactions have attracted fascinating advantages of tailorable thermodynamics stability, non-enzyme, and excellent assembly compliance to involvement in SNP identification. As the base mismatch position and amount in DNA sequence can be artificially adjusted, it provides plenty of selectivity and specificity for exploring perfect biosensors. Herein, a biosensor with double base mismatches mediated catalytic hairpin assembly (CHA) is designed via one base mismatch in the toehold domain and the other base mismatch in the stem sequence of hairpin 1 (H1) by triggering CHA reaction to achieve selective amplification of the mutation target (MT) and fluorescence resonance energy transfer (FRET) effect that is composed of Cy3 and Cy5 terminally attached H1 and hairpin 2 (H2). Depending on the rationally designed base mismatch position and toehold length, the fabricated biosensors show superior SNP detection performance, exhibiting a good linearity with high sensitivity of 6.6 fM detection limit and a broad detection abundance of 1%. The proposed biosensor can be used to detect the KRAS mutation gene in real samples and obtain good recoveries between 106 and 116.99%. Remarkably, these extendible designs of base mismatches can be used for more types of SNP detection, providing flexible adjustment based on base mismatch position and toehold length variations, especially for their thermodynamic model for DNA-strand displacement reactions.


Subject(s)
Base Pair Mismatch , Biosensing Techniques , Fluorescence Resonance Energy Transfer , Nucleic Acid Amplification Techniques , Polymorphism, Single Nucleotide , Biosensing Techniques/methods , Humans , Fluorescence Resonance Energy Transfer/methods , Nucleic Acid Amplification Techniques/methods , Limit of Detection , Inverted Repeat Sequences , DNA/chemistry , DNA/genetics , Mutation , Proto-Oncogene Proteins p21(ras)/genetics , Catalysis
14.
J Nanobiotechnology ; 22(1): 266, 2024 May 18.
Article in English | MEDLINE | ID: mdl-38762451

ABSTRACT

The detection of carcinoembryonic antigen (CEA) holds significant importance in the early diagnosis of cancer. However, current methods are hindered by limited accessibility and specificity. This study proposes a rapid and convenient Cas12a-based assay for the direct detection of CEA in clinical serum samples, aiming to address these limitations. The protocol involves a rolling machine operation, followed by a 5-min Cas12a-mediated cleavage process. The assay demonstrates the capability to detect human serum with high anti-interference performance and a detection limit as low as 0.2 ng/mL. The entire testing procedure can be accomplished in 75 min without centrifugation steps, and successfully reduced the limit of detection of traditional DNA walking machine by 50 folds. Overall, the testing procedure can be easily implemented in clinical settings.


Subject(s)
Biosensing Techniques , CRISPR-Cas Systems , Carcinoembryonic Antigen , DNA , Limit of Detection , Carcinoembryonic Antigen/blood , Humans , Biosensing Techniques/methods , DNA/chemistry , Endodeoxyribonucleases , Nucleic Acid Amplification Techniques/methods , CRISPR-Associated Proteins , Bacterial Proteins/genetics
15.
BMC Vet Res ; 20(1): 203, 2024 May 16.
Article in English | MEDLINE | ID: mdl-38755641

ABSTRACT

BACKGROUND: Avian influenza virus (AIV) not only causes huge economic losses to the poultry industry, but also threatens human health. Reverse transcription recombinase-aided amplification (RT-RAA) is a novel isothermal nucleic acid amplification technology. This study aimed to improve the detection efficiency of H5, H7, and H9 subtypes of AIV and detect the disease in time. This study established RT-RAA-LFD and real-time fluorescence RT-RAA (RF-RT-RAA) detection methods, which combined RT-RAA with lateral flow dipstick (LFD) and exo probe respectively, while primers and probes were designed based on the reaction principle of RT-RAA. RESULTS: The results showed that RT-RAA-LFD could specifically amplify H5, H7, and H9 subtypes of AIV at 37 °C, 18 min, 39 °C, 20 min, and 38 °C, 18 min, respectively. The sensitivity of all three subtypes for RT-RAA-LFD was 102 copies/µL, which was 10 ∼100 times higher than that of reverse transcription polymerase chain reaction (RT-PCR) agarose electrophoresis method. RF-RT-RAA could specifically amplify H5, H7, and H9 subtypes of AIV at 40 °C, 20 min, 38 °C, 16 min, and 39 °C, 17 min, respectively. The sensitivity of all three subtypes for RF-RT-RAA was 101 copies/µL, which was consistent with the results of real-time fluorescence quantification RT-PCR, and 100 ∼1000 times higher than that of RT-PCR-agarose electrophoresis method. The total coincidence rate of the two methods and RT-PCR-agarose electrophoresis in the detection of clinical samples was higher than 95%. CONCLUSIONS: RT-RAA-LFD and RF-RT-RAA were successfully established in this experiment, with quick response, simple operation, strong specificity, high sensitivity, good repeatability, and stability. They are suitable for the early and rapid diagnosis of Avian influenza and they have positive significance for the prevention, control of the disease, and public health safety.


Subject(s)
Chickens , Influenza A virus , Influenza in Birds , Nucleic Acid Amplification Techniques , Recombinases , Reverse Transcription , Animals , Influenza in Birds/virology , Influenza in Birds/diagnosis , Nucleic Acid Amplification Techniques/veterinary , Nucleic Acid Amplification Techniques/methods , Influenza A virus/genetics , Influenza A virus/classification , Influenza A virus/isolation & purification , Recombinases/metabolism , Sensitivity and Specificity , Poultry Diseases/virology , Poultry Diseases/diagnosis
16.
Biochem Biophys Res Commun ; 717: 150028, 2024 Jul 12.
Article in English | MEDLINE | ID: mdl-38714016

ABSTRACT

Mycoplasma pneumoniae (MP),as the most commonly infected respiratory pathogen in community-acquired pneumonia in preschool children,has becoming a prominent factor affecting children's respiratory health.Currently, there is a lack of easy, rapid, and accurate laboratory testing program for MP infection, which causes comparatively difficulty for clinical diagnostic.Here,we utilize loop-mediated isothermal amplification (LAMP) to amplify and characterize the P1 gene of MP, combined with nucleic acid lateral flow (NALF) for fast and visuallized detection of MP.Furthermore, we evaluated and analyzed the sensitivity, specificity and methodological consistency of the method.The results showed that the limit of detection(LoD) of MP-LAMP-NALF assay was down to 100 copys per reaction and there was no cross-reactivity with other pathogens infected the respiratory system. The concordance rate between MP-LAMP-NALF assay with quantitative real-time PCR was 94.3 %,which exhibiting excellent testing performance.We make superior the turnaround time of the MP-LAMP-NALF assay, which takes only about 50 min. In addition, there is no need for precision instruments and no restriction on the laboratory site.Collectively, LAMP-NALF assay targeting the P1 gene for Mycoplasma pneumoniae detection was a easy, precise and visual test which could be widely applied in outpatient and emergency departments or primary hospitals.When further optimized, it could be used as "point-of-care testing" of pathogens or multiple testing for pathogens.


Subject(s)
Molecular Diagnostic Techniques , Mycoplasma pneumoniae , Nucleic Acid Amplification Techniques , Pneumonia, Mycoplasma , Mycoplasma pneumoniae/genetics , Mycoplasma pneumoniae/isolation & purification , Nucleic Acid Amplification Techniques/methods , Humans , Pneumonia, Mycoplasma/diagnosis , Pneumonia, Mycoplasma/microbiology , Molecular Diagnostic Techniques/methods , Sensitivity and Specificity , Limit of Detection , DNA, Bacterial/genetics
17.
PLoS One ; 19(5): e0301234, 2024.
Article in English | MEDLINE | ID: mdl-38728290

ABSTRACT

Nucleic Acid Lateral Flow Assays (NALFAs) are a promising solution for the point-of-care detection of viruses like SARS-CoV-2. However, they show some drawbacks, such as the great dependency on the use of antibodies and the need for post-amplification protocols that enable the preparation of amplicons for effective readings, as well as low sensitivity. Here, we developed amplicons of a specific SARS-CoV-2 gene tailed with single-strand DNA (ssDNA) sequences to hybridize with DNA probes immobilized on the NALFA strips, thus overcoming the aforementioned problems. Results have shown that tailed primers have not compromised the amplification efficiency and allowed the correct detection of the amplicons in the lateral flow strip. This approach has presented a limit of detection (LOD) of 25 RNA copies /reaction mix (1 copy/µL) and the test of cross-reactivity with other related viruses has not shown any cross-reactivity. Twenty clinical samples were evaluated by NALFA and simultaneously compared with the gold standard RT-qPCR protocol, originating equal results. Although the number of clinical specimens tested being relatively small, this indicates a sensitivity and specificity both of 100%. In short, an alternative NALFA was successfully implemented, rendering an accurate route for SARS-CoV-2 diagnosis, compatible with low-resource settings.


Subject(s)
COVID-19 , RNA, Viral , SARS-CoV-2 , SARS-CoV-2/genetics , SARS-CoV-2/isolation & purification , Humans , COVID-19/diagnosis , COVID-19/virology , RNA, Viral/genetics , Limit of Detection , Nucleic Acid Amplification Techniques/methods , Sensitivity and Specificity , COVID-19 Nucleic Acid Testing/methods , DNA, Single-Stranded/genetics , DNA Primers/genetics , DNA Probes
18.
Anal Chim Acta ; 1302: 342486, 2024 May 08.
Article in English | MEDLINE | ID: mdl-38580404

ABSTRACT

BACKGROUND: Analysis of CpG methylation is informative for cancer diagnosis. Previously, we developed a novel method to discriminate CpG methylation status in target DNA by blocking recombinase polymerase amplification (RPA), an isothermal DNA amplification technique, using methyl-CpG binding domain (MBD) protein 2 (MBD2). The method was named MBD protein interference-RPA (MBDi-RPA). In this study, MBDi-RPA was performed using methyl-CpG binding protein 2 (MeCP2), another MBD family protein, as the blocking agent. RESULTS: MBDi-RPA using MeCP2 detected low levels of CpG methylation, showing that it had higher sensitivity than MBDi-RPA using MBD2. We also developed real-time RPA, which enabled rapid analysis of DNA amplification without the need for laborious agarose gel electrophoresis and used it in combination with MBDi-RPA. We termed this method real-time MBDi-RPA. The method using MeCP2 could determine the abundance ratio of CpG-methylated target DNA simply and rapidly, although highly sensitive detection was challenging. SIGNIFICANCE AND NOVELTY: Real-time MBDi-RPA using MeCP2 could be potentially useful for estimating CpG methylation status in target DNA prior to more detailed analyses.


Subject(s)
DNA Methylation , Nucleic Acid Amplification Techniques , DNA/chemistry , Nucleic Acid Amplification Techniques/methods , Recombinases
19.
Arch Virol ; 169(5): 94, 2024 Apr 09.
Article in English | MEDLINE | ID: mdl-38594417

ABSTRACT

Considering that avian leukosis virus (ALV) infection has inflicted massive economic losses on the poultry breeding industry in most countries, its early diagnosis remains an important measure for timely treatment and control of the disease, for which a rapid and sensitive point-of-care test is required. We established a user-friendly, economical, and rapid visualization method for ALV amplification products based on reverse transcription loop-mediated isothermal amplification (RT-LAMP) combined with an immunochromatographic strip in a lateral flow device (LFD). Using the ALVp27 gene as the target, five RT-LAMP primers and one fluorescein-isothiocyanate-labeled probe were designed. After 60 min of RT-LAMP amplification at 64 °C, the products could be visualized directly using the LFD. The detection limit of this assay for ALV detection was 102 RNA copies/µL, and the sensitivity was 100 times that of reverse transcription polymerase chain reaction (RT-PCR), showing high specificity and sensitivity. To verify the clinical practicality of this assay for detecting ALV, the gold standard RT-PCR method was used for comparison, and consistent results were obtained with both assays. Thus, the assay described here can be used for rapid detection of ALV in resource-limited environments.


Subject(s)
Avian Leukosis Virus , Molecular Diagnostic Techniques , Reverse Transcription , Animals , Avian Leukosis Virus/genetics , Sensitivity and Specificity , Nucleic Acid Amplification Techniques/methods
20.
Biotechnol J ; 19(4): e2400026, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38622795

ABSTRACT

Single-stranded DNA (ssDNA) is the foundation of modern biology, with wide applications in gene editing, sequencing, DNA information storage, and materials science. However, synthesizing ssDNA with high efficiency, high throughput, and low error rate in vitro remains a major challenge. Various methods have been developed for ssDNA synthesis, and some significant results have been achieved. In this review, six main methods were introduced, including solid-phase oligonucleotide synthesis, terminal deoxynucleotidyl transferase-based ssDNA synthesis, reverse transcription, primer exchange reaction, asymmetric polymerase chain reaction, and rolling circle amplification. The advantages and limitations of each method were compared, as well as illustrate their representative achievements and applications. Especially, rolling circle amplification has received significant attention, including ssDNA synthesis, assembly, and application based on recent work. Finally, the future challenges and opportunities of ssDNA synthesis were summarized and discussed. Envisioning the development of new methods and significant progress will be made in the near future with the efforts of scientists around the world.


Subject(s)
DNA, Single-Stranded , DNA , DNA, Single-Stranded/genetics , Polymerase Chain Reaction/methods , DNA-Directed DNA Polymerase , Oligonucleotides , Nucleic Acid Amplification Techniques/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...